Skip links

YORVIPATH® (palopegteriparatide)

Full Name YORVIPATH® (palopegteriparatide)
Drug Yorvipath
Manufacturer Ascendis Pharma
Route of Administration Subcutaneous
Site of Care Home
Approved Indication The treatment of hypoparathyroidism in adults
Disease Hypoparathyroidism
Therapeutic Area Endocrinology
Enrollment Form Link Enrollment Form
Phone Number 888-204-7802
Fax Number 877-471-8175
Product Website yorvipathhcp.com